Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 612

TwinStrand completes series A sequence

Alexandria Venture Investments has helped UW's genetic sequencing technology developer TwinStand raise series A financing.

Jan 10, 2020

TwinStrand completes $16m series A sequence

Existing investor Alexandria Venture Investments has helped genetic sequencing technology developer TwinStand increase its overall funding to $21.5m.

Jan 10, 2020

Soul Machines personifies $40m series B

University of Auckland Inventors Fund has contributed to a $40m series B round for AI-based avatar developer Soul Machines, with the investment led by Temasek.

Jan 10, 2020

Daily deal net: January 9, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jan 9, 2020

Quibi cribs another $400m

The bite-sized video streaming platform, which counts a host of corporates among its investors, has revealed $400m in funding along with its launch date.

Jan 9, 2020

Virtual Incision sews up $20m

The colectomy-focused robotic surgical device developer has now assembled $51.7m having spun out from University of Nebraska Medical Center in 2006.

Jan 9, 2020

VectivBio begins with $35m

Inserm Transfer Initiative featured in the first round for VectivBio, a short bowel syndrome treatment developer spun out of Therachon following the latter's acquisition by Pfizer.

Jan 9, 2020

ClassPass clinches $285m series E

The GV-backed fitness and wellness subscription service secured a unicorn valuation in a round that lifted its overall funding to $540m.

Jan 9, 2020

Tiger Global buys into Byju's with $200m

The educational app developer, which counts Tencent, Naspers and BCC among its investors, raised the money at a valuation of about $8bn.

Jan 9, 2020

VectivBio selects Novo for $35m round

Novo took part in the first round for VectivBio, a short bowel syndrome treatment developer launched out of genetic disease drug developer Therachon.

Jan 9, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here